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Abstract
Graph analysis was used to study the effects of accelerated intermittent theta burst stimulation
(aiTBS) on the brain's network topology in medication-resistant depressed patients. Anatomical
and resting-state functional MRI (rs-fMRI) was recorded at baseline and after sham and verum
stimulation. Depression severity was assessed using the Hamilton Depression Rating Scale
(HDRS). Using various graph measures, the different effects of sham and verum aiTBS were
calculated. It was also investigated whether changes in graph measures were correlated to clini-
cal responses. Furthermore, by correlating baseline graph measures with the changes in HDRS
in terms of percentage, the potential of graph measures as biomarker was studied. Although no
differences were observed between the effects of verum and sham stimulation on whole-brain
graph measures and changes in graph measures did not correlate with clinical response,
the baseline values of clustering coefficient and global efficiency showed to be predictive of the
clinical response to verum aiTBS. Nodal effects were found throughout the whole brain. The
distribution of these effects could not be linked to the strength of the functional connectivity
between the stimulation site and the node. This study showed that the effects of aiTBS on
graph measures distribute beyond the actual stimulation site. However, additional research into
the complex interactions between different areas in the brain is necessary to understand the
effects of aiTBS in more detail.
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1 | INTRODUCTION
Transcranial magnetic stimulation (TMS) is a well-established noninva-
sive neurostimulation technique used in a variety of experimental
and clinical applications. A time-varying current is sent through a coil
placed tangential to the scalp. The magnetic field, induced by this time-
varying current, induces an electric field within the neural tissue in the
brain, which is parallel to the current in the coil but has opposite direc-
tion. This electric field within the brain is able to modulate the activity
of cortical neurons (Wagner, Valero-Cabre, & Pascual-Leone, 2007).
The effects of the repetitive application of TMS (rTMS) endure
beyond the actual period of stimulation, affecting larger networks in
the brain, which makes rTMS a potential treatment for various neuro-
psychiatric disorders (Klooster et al., 2016). The application of high-
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frequency rTMS, delivering pulses at a frequency higher than 5 Hz, is
currently FDA approved as treatment for patients with medication
resistant major depressive disorder (MDD), which is approximately
one-third of all MDD patients. Left prefrontal high-frequency rTMS has
shown to be an effective and safe treatment in adult MDD patients
documented as medication resistant (Pascual-Leone, Rubio, Pallardó, &
Catalá, 1996; George et al. 2010; George, Taylor, & Baron Short, 2013;
Padberg & George, 2009; Baeken et al., 2013; Loo, McFarquhar, &
Mitchell, 2008). The rationale to stimulate these parts of the cortex is
based on earlier studies showing clear involvement of the prefrontal
cortex (PFC) in the pathophysiology of MDD (Koenigs & Grafman,
2009). More specifically, the ventromedial PFC (VMPFC) shows hyper-
activity, whereas the dorsolateral PFC (DLPFC) shows hypoactivity, as
demonstrated by multiple imaging studies (Mulders, van Eijndhoven,
Schene, Beckmann, & Tendolkar, 2015). Reversing these effects—
decreasing the activity of the VMPFC or increasing the activity of the
DLPFC—has been proposed as a possible mechanism by which rTMS
treatment can achieve response and remission from depressive symp-
toms (George, 2010; Seminowicz et al., 2004).
Standard rTMS guidelines to treat depression follow mostly a
daily pattern, with applied frequencies from 1 to 20 Hz, repeated for
4–6 weeks (Perera et al., 2016). With such protocols, clinical effec-
tiveness remains however rather modest. To improve clinical out-
come, new treatment parameters are currently under investigation.
One new approach is accelerated rTMS, where a similar amount of
stimulation sessions is concentrated over a couple of days instead of
the more conventional daily sessions, spread over multiple weeks.
Another line of research focuses on theta burst stimulation (TBS)
(Huang, Edwards, Rounis, Bhatia, & Rothwell, 2005), where a particu-
lar set of parameter deliverables applies bursts of 3 stimuli at 50 Hz
and is repeated every 200 ms (5 Hz, theta range). TBS has shown
comparable clinical efficacy compared to rTMS but stimuli are deliv-
ered during a shorter period and usually with a lower intensity
(Blumberger, Vila-rodriguez, Knyahnytska, et al., 2018). Intermittent
TBS (iTBS), the administration of 2 s of TBS alternated with 8 s rest,
has been investigated for treatment of MDD (Bakker et al., 2015;
Chistyakov, Rubicsek, Kaplan, Zaaroor, & Klein, 2010; Li et al., 2014),
based on the excitatory character of the standard iTBS protocol
(600 stimuli at 80% active motor threshold) (Huang et al., 2005).
To maximize clinical efficacy within a shorter time period, an
intensive accelerated iTBS (aiTBS) protocol, consisting of multiple
iTBS sessions per day, was recently tested as possible treatment for
depression in our group. Duprat et al. (2016) showed a rapid signifi-
cant decrease in depression severity symptoms assessed with the
17-item Hamilton Depression Rating Scale (HDRS) (Hamilton, 1967)
after 4 stimulation days. Although clinical effects were found both
after sham and verum aiTBS, the most meaningful clinical outcomes
regarding response and remission were observed 2 weeks after the
aiTBS protocol, during follow-up. While only 28% of the patients
showed a 50% reduction of their initial HDRS score at the end of the
stimulation procedure, response rates mounted up to 38% 2 weeks
later, indicating delayed clinical effects. Furthermore, 30% of the
responders were considered in clinical remission.
How aiTBS has the potential to improve depression symptoms
over such a limited period in medication resistant MDD patients
remains to be elucidated. Because it is known that the effects of stim-
ulation are propagated through the brain via anatomical and functional
connections (Amico et al., 2017; Fox et al., 2014), the effect of aiTBS
might occur on a network level. In this study, the effect of this aiTBS
protocol on the brain's network topology is investigated by means of
graph analysis derived from resting-state functional MRI (rs-fMRI)
data of a group of MDD patients. Graph analysis is a mathematical
concept to quantify networks, for example, brain networks, according
to various neurobiologically meaningful properties such as integration
and segregation (Bortoletto, Veniero, Thut, & Miniussi, 2015;
Rubinov & Sporns, 2010). Combining rs-fMRI datasets before and
after a brain stimulation protocol with graph analysis allows one to
map the network changes throughout the whole brain induced by
TMS, instead of just looking at single connections at a time, as it is
done in many functional connectivity studies.
Previous studies have investigated the brain's network topology
in patients with MDD. Graph analyses were performed based on corti-
cal thickness (Mak, Colloby, Thomas, & O'Brien, 2016), voxel based
morphometry measures (Lim, Jung, & Aizenstein, 2013), structural
connectivity using diffusion MRI data (Ajilore et al., 2014; Chen et al.,
2016; Korgaonkar, Fornito, Williams, & Grieve, 2014; Singh et al.,
2013), or functional connections using rs-fMRI datasets (Bohr et al.,
2013; Li et al., 2016). The reported differences in graph measures
between healthy volunteers and MDD patients were ambiguous. On
one hand, some studies did not find differences, and on the other
hand, increases in clustering coefficient, local efficiency, and path
lengths were reported.
To study the effects of stimulation on network level, only few
studies have been performed combining brain stimulation and graph
theory: for example, Shafi et al. (2014) and Deng et al. (2015) used
resting EEG data to examine the effects of continuous TBS and rTMS
respectively. Shafi et al. (2014) showed frequency band dependent
effects of stimulation on clustering coefficient and local efficiency: the
beta band showed increases in clustering coefficient after cTBS,
whereas alpha band showed decreases in clustering coefficient along
with increased path length. Deng et al. (2015) showed reduced small-
worldness in the beta frequency band after stimulation. Vecchio
et al. (2018) performed source localization on EEG data recorded
before and after transcranial direct current stimulation (tDCS) and
showed that anodal tDCS over the motor cortex reduces small-world-
ness. Park et al. (2014), Polanía et al. (2011), and Cocchi et al. (2015)
studied the effects of various stimulation techniques using task fMRI
and rs-fMRI data. Park observed a correlation between the motor per-
formance change and the increase and decrease in global and local
efficiency respectively, induced by 10 Hz rTMS (Park et al., 2014).
Cocchi showed different effects of continuous versus inhibitory TBS
represented by modularity, out-degree participation index, and
within-module degree (Cocchi et al., 2015). Polanía et al. (2011) com-
bined anodal tDCS over the motor cortex with rs-fMRI derived graph
measures and found increases in path length in the somatomotor
areas after stimulation.
Besides the effect of aiTBS on graph measures, it will clinically be
relevant to investigate if graph measures can be used as biomarkers to
predict the outcome of this stimulation protocol. Previously, it has
been shown that rs-fMRI connectivities can be used for this purpose.
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Drysdale et al. (2016) derived four depression subtypes that seem to
respond differently to rTMS treatment. And Fox et al. (2012, 2013)
demonstrated that the clinical effects of rTMS are linked to the
functional anti-correlation between the subgenual anterior cingulate
cortex (sgACC) and the stimulation spot in the left DLPFC. This anti-
correlation between the sgACC and parts of the left superior medial
prefrontal cortex was also suggested to have predictive value for the
outcome of accelerated rTMS in a cohort of MDD patients (Baeken
et al., 2014), although in another accelerated iTBS this was not found
to be that straightforward (Baeken, Duprat, Wu, De Raedt, & van
Heeringen, 2017a). Nevertheless, Downar et al. (2014) showed in a
cohort of MDD patients that the graph measure betweenness central-
ity can be used to distinguish responders from nonresponders to
rTMS to the dorsomedial prefrontal cortex.
Specifically, this is the first study using graph analysis to investi-
gate the clinical effects of the relatively new aiTBS treatment proto-
col. Graph analysis was performed on the whole-brain level, using the
clustering coefficient, global efficiency, small-worldness, and modular-
ity, and on the nodal level, using the degree, and the betweenness
centrality as graph measures. Due to the presumably excitatory char-
acter of iTBS, we hypothesized that aiTBS would increase all four
whole-brain graph measures. On nodal level, we expected to find
mostly increases in degree and betweenness centrality in nodes
related to the pathophysiology of MDD. Furthermore, we expected
that changes in graph measures would be linked to the clinical
response. We also hypothesized that changes in functional connectiv-
ity, expressed by graph measures, would not only occur in the stimu-
lated area (the left DLPFC), but will also be present in functionally
connected regions.
2 | METHODS
This study (http://clinicaltrials.gov/show/NCT01832805) was
approved by the local Ghent University Hospital ethics committee
and is in accordance with the declaration of Helsinki (2004). All
patients gave written informed consent.
2.1 | Inclusion criteria
Fifty right-handed MDD patients were included in this study. MDD
was diagnosed using the structured Mini-International Neuropsychiat-
ric Interview (MINI; Sheehan et al., 1998). All patients were at least
stage I treatment resistant according to the Rush criteria (Rush,
Thase, & Dube, 2003). They had a minimum of one unsuccessful treat-
ment trial with selective serotonin reuptake inhibitors/serotonin and
norepinephrine reuptake inhibitors (SSRI/SNRI). Medication was
tapered off before the aiTBS treatment period, so all were
medication-free for at least 2 weeks before the start of the first stim-
ulation session. More extensive information about the patients and
clinical outcome can be found in Duprat et al. (2016).
2.2 | Data acquisition
The overall design of this randomized, sham-controlled, double-
blinded, cross-over trial is shown in Figure 1. Patients were random-
ized to receive first sham aiTBS followed by verum aiTBS (arm A in
Figure 1) or the other way around (arm B in Figure 1). All patients first
underwent baseline MRI (3 T Siemens TrioTim, Erlangen, Germany) on
day 1 (T1) with anatomical imaging (MPRAGE, TR = 2,530 ms, TE =
2.58 ms, FA = 7, FOV = 220 × 220 mm2, resolution = 0.9 × 0.9 ×
0.9 mm3, 176 slices) and rs-fMRI (EPI, TR = 2,000 ms, TE = 29 ms,
FA = 90, FOV = 192 × 192 mm2, resolution = 3 × 3 × 3 mm3, slice
thickness/gap = 3/1 mm, 40 slices, 300 volumes, TA = 10.12 min).
During the resting-state measurement, patients were asked to stay
awake with their eyes closed. On Days 2–5 and Days 9–12, verum or
sham aiTBS was applied depending on the randomization order. A
Magstim Rapid2 Plus1 magnetic stimulator (Magstim Company Lim-
ited, Wales, UK) connected to a verum or sham figure-of-eight shaped
coil (Magstim 70 mm double air film [sham] coil) was used to apply
the verum and sham stimulation respectively. On the 8th day (T2) and
FIGURE 1 Design of the accelerated iTBS treatment procedure. After a washout period, all patients are at least 2 weeks anti-depressant free
before they are randomized to receive verum and sham accelerated iTBS treatment. Scheme adapted from Duprat et al. (2016) [Color figure can
be viewed at wileyonlinelibrary.com]
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on the 15th day (T3), so 3 days after the stimulation, the imaging pro-
tocol was repeated. At the same days when imaging was performed
(T1, T2, and T3) and additionally 2 weeks after the last stimulation
(T4), depression severity symptoms were assessed using the 17-item
HDRS questionnaire (Hamilton, 1967).
Before the first stimulation session, the resting motor threshold
(rMT) was determined based on motor evoked potentials (MEPs)
induced in the right abductor pollicis brevis (APB) after applying single
pulses to the hotspot. During four consecutive days, five daily ses-
sions of iTBS were applied at 110% rMT to the left DLPFC: the center
part of the midprefrontal gyrus (Brodmann area 9/46) based on struc-
tural MRI of each individual (Peleman et al., 2010). Positioning of the
coil was maintained with the BrainSight neuronavigation system
(Brainsight™, Rogue Resolutions, Inc). One iTBS session consisted of
54 trains of 10 bursts of 3 stimuli. Two seconds of stimulation were
given in an 8 second cycling period. This adds up to 1,620 stimuli per
session with a total number of 32,400 stimuli during the four-day
treatment. There were breaks of ~15 min between the stimulation
sessions. During the stimulation, patients were blindfolded, wore ear-
plugs, and were kept unaware of the type of stimulation (sham or
verum) they received.
2.3 | Graph analysis
Functional connectivity analyses were performed using the rs-fMRI
data from T1 and T2. In this first week of the study design, patients
received either sham or verum aiTBS depending on the order of ran-
domization. The second part of the study protocol, the period
between T2 and T3 after the cross-over, was not used to be able to
study the pure effects of sham and verum aiTBS. The duration of the
after-effect of 4 days aiTBS is not yet known and as there was only a
weekend between the stimulation weeks, effects of verum and sham
might be crossed over into the second week.
Data were preprocessed with MATLAB 2015b (The Mathworks
Inc., Natrick, MA) and SPM12 (Wellcome Trust Centre for Neuroimag-
ing, London, UK) according to standard steps. After realignment, vol-
umes with excessive motion, quantified as >0.3 mm framewise
displacement, were discarded for further analysis. Complete datasets
were excluded if more than 100 volumes had to be removed (see
Appendix A, Figure A1). Six motion regressors, and additionally a
white-matter and cerebrospinal fluid regressor were used to correct
the data using SPM's REST toolbox (Song et al., 2011). The latter two
regressors were defined as the mean of the time-series within the
eroded white-matter and cerebrospinal fluid masks, respectively. Tem-
poral bandpass filtering was applied with cutoff frequencies of 0.1
and 0.01 Hz.
The brain datasets were parcellated using the parcellation scheme
from Drysdale et al. (2016), using the 264 parcels, further referred to
as nodes, from Power et al. (2011) and additionally 13 subcortical gray
matter structures (see Appendix A, Table A1 for additional informa-
tion). For all nodes, the mean time-series was computed by averaging
all the voxel time-series belonging to that node. The temporal signal-
to-noise ratio (tSNR) criterion was used to remove nodes with
unreliable time-series from further analyses. Nodes were discarded if
tSNR <40 in more than 10% of the datasets (Liston et al., 2014).
Furthermore, if more than 10% of the nodes within one dataset had
tSNR <40, the dataset (both T1 and T2) were removed from further
analysis (Appendix Figure A2).
For every patient and for both time points (T1 and T2), a connec-
tivity matrix was calculated as the Pearson correlation between all the
node time-series, herewith rejecting the first 10 volumes to ensure
scanner stability. The connections in this connectivity matrix are fur-
ther referred to as edges. All edges are scaled to be in the range
between zero and one (Schwarz & McGonigle, 2011) in a three-step
process. First, the range of the connectivity matrix was defined by
subtracting the minimum value from the maximum value. Second, all
edge-values were divided by the range. Last, the minimum value of
the new matrix was added which results in a scaled matrix between
zero and one. This method was repeated for every subject and for
every time-point separately.
The MATLAB-based Brain Connectivity Toolbox (Rubinov &
Sporns, 2010) and the Graph Analysis Toolbox (Hosseini, Hadi,
Hoeft, & Kesler, 2012) were used to calculate graph measures that
quantify the brain's network organization (Bullmore & Sporns, 2009,
2012; Rubinov & Sporns, 2010). On whole-brain level, four weighted
graph parameters were calculated from every connectivity matrix:
clustering coefficient, global efficiency, small-worldness, and modular-
ity. Here, high clustering coefficients are associated with high local
efficiency regarding information transfer and robustness (Bullmore &
Sporns, 2009). The modularity measure represents the way in which a
network can be subdivided into modules: groups of nodes with a high
number of within-group links and a low number of between-group
connections (Girvan & Newman, 2002; Newman, 2004). Functional
integration can be described by path length and efficiencies. High
functional connectivity values can be translated to short path lengths
and high efficiencies. The path length is the average of the shortest
routes of information flow between pairs of nodes. Global efficiency
can be calculated by inverting the path lengths. Moreover, the small-
worldness was calculated. Small-world networks are assumed to be
efficient, both locally and globally (Rubinov & Sporns, 2010). To calcu-
late the small-worldness, the clustering coefficient and path length
were normalized by dividing them by their equivalents derived from
random networks. Random networks were obtained using 20 randomi-
zation steps, leaving the degree of the connectivity matrix unchanged.
On the nodal level, two graph measures were calculated: the
betweenness centrality and the degree. The betweenness centrality
represents the fraction of shortest paths that pass through a certain
node. Degree is a measure of interaction and can be calculated as the
summation of all functional connections per node.
In general, graph measures are known to depend on the number
of nodes and the average degree within a network (Wijk, Van, Stam, &
Daffertshofer, 2010). Therefore, to obtain robust measures, every
graph measure was calculated for a range of densities. The lowest
density was set to 28% to prevent disconnected networks. The full
density range comprises densities between 28 and 50% (in steps of
2%). Above 50%, connections are thought not be physiologically
meaningful (Hosseini, Hoeft, & Kesler, 2012; Kaiser & Hilgetag, 2006).
The area under the curve was calculated over this whole density range
to obtain one robust, representative value for the graph measure per
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patient, per time-point, and in case of the nodal analysis also
per node.
2.4 | Statistical analysis
In this study, functional connectivity, represented by various graph
measures, was compared between T1 and T2 (Figure 1). Here, ΔGM is
the change in graph measure (GMT2 − GMT1), and referred to as the
effect size. Because of non-normality of the graph parameters (see
Appendix B), nonparametric permutation tests using 1,000 permuta-
tions were performed to investigate the difference between sham and
verum stimulation on graph measures (ΔGMsham vs ΔGMverum).
Significance level was set to p < .05 for the whole-brain analysis.
On the nodal level, additional multiple comparison correction was
applied via the Holm–Bonferroni method, using the number of nodes
for correction, but all findings with p < .05 were reported. Post-hoc
t tests were used to investigate the direction of the effects.
2.5 | Spatial distribution
To study the assumption that the effect of aiTBS distributes via func-
tional connections, the functional connectivity between the stimula-
tion position in the left DLPFC and all the nodes showing an effect of
verum stimulation over sham stimulation were calculated and corre-
lated with the effect size. A circular region of interest (ROI), with a
diameter of 1 cm, was positioned at the average stimulation position
and a time-series was derived by averaging all the time-series of the
gray-matter voxels within the ROI.
2.6 | Biomarker investigation
To investigate the predictive value of graph parameters on the clinical
response to aiTBS, the baseline graph measures were correlated with
the change in HDRS in terms of percentage (T2 with respect to T1 in
the subgroup of patients receiving verum stimulation). Here, this
means the lower the scores on HDRS changes in terms of percentage,
the better the clinical response. Only significant correlations (p < .05)
were reported.
3 | RESULTS
Given five drop-out patients (due to a different diagnosis retrospec-
tively, clinical improvement before the stimulation, or incomplete or
wrongly timed MRI datasets), exclusion of seven patients (due to
excessive motion in the MRI dataset at either T1 or T2), exclusion of
three subjects based on the tSNR criterion, and three subjects did not
have connected graphs within the density range, data from 32 patients
were used for analysis. Of these patients, 14 received sham stimula-
tion between T1 and T2 (arm A in Figure 1) and 18 received verum
stimulation (arm B in Figure 1). Patient details and results on the
clinical outcome of this stimulation protocol can be found in Duprat
et al. (2016). Based on the tSNR criteria, 19 nodes (represented in red
in Figure 2) were removed. Detailed information about the excluded
nodes can be found in Appendix A, Table A2.
3.1 | Whole-brain network topology changes
On the whole-brain level, stimulation caused a significant effect on
clustering coefficient and global efficiency (p values <.01, <.01, .072,
and .607 for clustering coefficient, global efficiency, modularity, and
small-worldness, respectively) (Appendix B). However, the effects did
not differ between the subgroups receiving sham and verum stimula-
tion. An overview can be found in Table 1. As can be seen in Table 2,
changes in graph measures were not significantly correlated with
changes in clinical outcome.
3.2 | Changes in nodal graph measures
Figure 3 and Table 3 provide an overview of the nodes with signifi-
cantly (p < .05) different effects of sham versus verum aiTBS. Only
the betweenness centrality in the right supplementary motor area sur-
vived Bonferroni correction for multiple comparisons.
For all the nodes that showed a significantly different effect of
sham versus verum stimulation, it was investigated if changes in graph
measures were correlated with changes in clinical improvement.
FIGURE 2 Overview of nodes used for graph analysis. After applying a tSNR criterion (at least 90% of the nodes should have tSNR >40),
19 nodes were excluded from the graph analysis (marked in red) [Color figure can be viewed at wileyonlinelibrary.com]
TABLE 1 Statistical overview of p values (permutation test with
1,000 permutations) representing the effect of stimulation type
(verum vs sham) on whole-brain graph measures
Graph measure
p value
(tail = −1)
p value
(tail = 0)
p value
(tail = 1)
Clustering coefficient .656 .688 .344
Global efficiency .94 .12 .06
Modularity .199 .378 .801
Small-worldness .528 .944 .472
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Table 4 shows an overview of the significant (p < .05) findings. A full
overview can be found in Appendix C.
3.3 | Propagation of effect via functional
connections
The mean stimulation position within the left DLPFC within all
32 patients was [−38, 20, 54] (MNI coordinates in mm).
For both graph measures that were calculated on nodal level, the
functional connectivities between the stimulation site and the nodes
with significant (p < .05) effect sizes were correlated with the p values.
Figure 5 shows an overview of correlations, split into overall effects
(absolute values of the functional connectivity) and negative and posi-
tive functional connections. Statistical details are summed in Table 5.
No significant correlations were found. However, only based on find-
ings within nine nodes, a large negative slope was found between the
functional connectivity and the effect size of stimulation on the
degree. This suggests that the effect of aiTBS on degree depends on
the functional connectivity with the stimulation site: higher functional
connectivities are linked to higher effect sizes (lower p values).
3.4 | Potential of graph measures as biomarker
Figure 6 shows an overview of the baseline whole-brain graph mea-
sures versus the percentage of change in HDRS score, after versus
before verum stimulation. Table 6 shows the statistical values.
Both the clustering coefficient and the global efficiency show a
significant correlation between the baseline values and the changes in
clinical well-being. The negative correlation coefficient and slope indi-
cate that higher baseline values may predict higher clinical effect of
verum aiTBS.
A comparable analysis was performed on the nodal level, using
the degree and the betweenness centrality as graph measures.
Figure 7 shows an overview of the nodes showing significant (p < .05)
effects and the belonging statistics can be found in Table 7.
4 | DISCUSSION
This study aimed to use graph theoretical analysis to investigate the
effects of the relatively new accelerated stimulation protocol to treat
MDD patients, namely aiTBS, on the brain's network organization.
4.1 | The effect of aiTBS on graph measures
4.1.1 | Whole-brain results
On the whole-brain level, no significant differences between the
effects of verum stimulation versus sham stimulation were found, and
changes in graph measures did not correlate with changes in depres-
sion severity symptoms. Previous studies (Ajilore et al., 2014; Lim
et al., 2013) found no differences between graph measures clustering
TABLE 2 Correlation between the changes in whole-brain graph measures versus the changes in clinical well-being (after vs before stimulation)
All subjects Sham stimulated subjects Verum stimulated subjects
Correlation coefficient p value Correlation coefficient p value Correlation coefficient p value
Clustering coefficient −0.21 .242 −0.35 .227 −0.20 .437
Global efficiency −0.21 .254 −0.43 .125 −0.24 .344
Modularity −0.07 .724 −0.03 .918 −0.03 .916
Small-worldness 0.11 .551 0.21 .474 0.07 .796
FIGURE 3 Overview of nodes showing significantly different effects of sham and verum aiTBS on (a) graph measures degree and
(b) betweenness centrality [Color figure can be viewed at wileyonlinelibrary.com]
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coefficients, path lengths, and small-worldness in healthy subjects and
patients with late-life depression on whole-brain level. Clinical effec-
tiveness might not be linked to changes in whole-brain graph mea-
sures. Even though aiTBS treatment in MDD patients does not
influence the whole-brain's network topology, it may have effects
within subnetworks. Indeed, Tik et al. (2017) recently showed
network-specific increases in functional connectivity in one specific
resting-state network, containing the stimulated left DLPFC and the
sgACC, after 10 Hz rTMS in a population of healthy subjects.
4.1.2 | Nodal results
On the nodal level, some nodes showed significantly different
responses to verum and sham stimulation. Because these nodes are
TABLE 3 Statistical overview of the node showing a significantly different effect between sham and verum aiTBS. Effects were defined as the
change in graph measure (T2–T1)
Node number Node name p value
Correlation with
stimulation site
Mean effect
(sham patients)
Mean effect
(verum patients)
Degree
17 L paracentral lobule .034 <0.01 1.921 −1.507
29 R precentral .026 <0.01 1.677 −1.885
46 R postcentral .027 0.07 −1.831 1.689
51 L cingulo-opercular .008 −0.07 −2.647 2.746
53 R supp motor area .038 0.01 −2.099 1.802
57 L cingulo-opercular .02 −0.04 3.619 −0.609
59 L cingulo-opercular (mid cingulum) .016 0.01 −1.514 3.643
65 L supramarginal (auditory) .049 −0.10 −1.873 1.389
69 L supramarginal (auditory) .03 −0.07 0.950 −2.577
112 L frontal sup medial .007 0.25 −1.851 2.121
113 L anterior cingulum .049 0.12 −0.921 1.769
119 R mid temporal .026 0.07 −3.112 0.448
124 L parahippocampal .001 −0.07 2.534 −3.512
167 L cuneus .031 −0.13 −0.886 2.639
218 R frontal middle .039 0.02 0.365 3.851
233 R subcortical .033 0.09 1.878 −2.227
243 L cerebellum .033 −0.04 1.753 −2.101
260 L middle occipital .048 −0.05 0.620 −2.632
Betweenness centrality
7 R parahippocampal .034 −0.03 −0.359 15.132
16 R supp motor area 0* −0.03 13.547 −22.387
17 L paracentral lobule .01 <0.01 10.903 −16.448
29 R precentral .039 0.03 −3.283 8.738
45 L postcentral .033 −0.04 6.856 −13.340
63 R temporal sup .012 −0.10 4.909 −15.901
64 L rolandic oper .009 −0.04 −22.929 1.287
97 R frontal sup .003 0.16 10.439 −9.238
101 R frontal sup .026 0.06 7.773 −6.713
119 R temporal mid .003 0.07 −13.196 10.489
124 L parahippocampal .025 −0.07 −17.820 2.300
133 L cingulum post .028 0.12 15.210 2.517
154 L occipital inf .021 −0.12 9.576 −7.326
161 R temporal inf .004 −0.02 8.237 −12.659
179 R temporal inf .029 - < 0.01 6.494 −5.580
194 R angular .04 0.08 6.676 −7.374
196 R frontal mid .045 0.16 9.377 −0.447
198 L frontal mid orb .024 0.14 −11.100 4.519
213 L supp motor area .015 −0.07 −14.444 3.072
227 L putamen .023 0.03 −12.493 7.018
228 L subcortical .011 0.08 −15.480 16.380
235 R temporal sup .031 0.01 −11.220 3.228
268 L caudate .004 0.05 −18.123 4.126
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TABLE 4 Overview of nodes showing significant (p < .05) correlation between the changes in graph measures versus the changes in depression
severity
All subjects Sham stimulated subjects Verum stimulated subjects
Node number Node name
Correlation
coefficient p value
Correlation
coefficient p value
Correlation
coefficient p value
Degree
124 L parahippocampal −0.07 .69 −0.58 .03 −0.03 .90
Betweenness centrality
45 L postcentral 0.60 <.01 0.69 .01 0.51 .03
213 L supp motor area −0.33 .06 0.04 .90 −0.65 <.01
FIGURE 4 Functional connectivity (FC) with the stimulation area in the left DLPFC (MNI [−38, 20, 54]) as seed region. The volume shows the
overall connectivity map obtained from neurosynth.org. Functional correlations with the nodes are shown in yellow and blue for positive and
negative connections, respectively. The size of the nodes represents the strength of the connectivity [Color figure can be viewed at
wileyonlinelibrary.com]
FIGURE 5 Correlation between the functional connectivities (FC) between the stimulation site in the left DLPFC and the nodes showing effects
of verum stimulation with respect to sham stimulation and the strength of the effect. Statistical details can be found in Table 5 [Color figure can
be viewed at wileyonlinelibrary.com]
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spread throughout the whole brain, this indicates that the effects of
aiTBS are not restricted to the stimulation site. The nodes in proximity
to the stimulated left DLPFC did not show differences between sham
and verum responses. The direction of effects varied between nodes.
Some nodes displayed significantly larger increases in graph measures
after verum or sham stimulation and others showed increases after
sham and decreases after verum or vice versa. Previously, it was dem-
onstrated in similar types of MDD patients that clinical improvement
after an accelerated high frequency rTMS paradigm was associated
with significant increases of GABA (γ-aminobutyric acid) concentra-
tions in the stimulated area (the same left DLPFC spot that was also
targeted here in this study) (Baeken, Lefaucheur, & Van Schuerbeek,
2017b). These GABA increases must be primarily considered as an
“excitation” of GABAergic inhibitory neurons and pathways
(Lefaucheur, Drouot, Ménard-Lefaucheur, Keravel, & Nguyen, 2006).
Both Kang et al. (2016) and Liston et al. (2014) have reported
reductions in connectivity after 10 Hz rTMS, which is also assumed to
have excitatory effects. However, one needs to keep in mind that
according to Huang et al. (2005), the standard iTBS protocol is
thought to result in excitatory effects. The aiTBS protocol is a modi-
fied form of the original iTBS protocol, not only in the number of
pulses but also in the number of sessions. As it is known that modifi-
cations of stimulation protocols are able to reverse the polarity of the
after-effects (Gamboa et al., 2011; Gamboa, Antal, Moliadze, & Pau-
lus, 2010; Gentner, Wankerl, Reinsberger, Zeller, & Classen, 2008;
Murakami, Müller-Dahlhaus, Lu, & Ziemann, 2012), it remains to be
determined whether the net effects in the stimulated and connected
areas are excitatory or inhibitory.
4.1.3 | Specific nodal effect
The most significant result (also the only finding that survived Bonfer-
roni correction) was observed in the right supplementary motor area.
Whereas the betweenness centrality increased after verum stimula-
tion, it decreased after sham stimulation. This means that shortest
paths between brain regions pass the right supplementary motor area.
TABLE 5 Statistical details about the correlations between the
functional connectivity and the effect size (belonging to Figure 5)
Correlation coefficient Slope p value
Degree
All −0.20 −0.86 .42
Negative 0.12 0.26 .77
Positive −0.44 −2.74 .24
Betweenness centrality
All 0.09 0.32 .69
Negative −0.06 −0.17 .88
Positive 0.10 0.37 .74
TABLE 6 Statistical overview of the biomarker potential of the four
whole-brain graph measures
Graph measure Correlation coefficient Slope p value
Clustering coefficient −0.55 −20.3 .019
Global efficiency −0.57 −42.5 .014
Modularity −0.45 −18.18 .058
Small-worldness 0.33 9.93 .173
FIGURE 6 Potential of whole-brain graph measures clustering coefficient, global efficiency, modularity, and small-worldness to predict the
percentage of clinical change of verum aiTBS. Statistical details can be found in Table 6 [Color figure can be viewed at wileyonlinelibrary.com]
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FIGURE 7 Nodes showing a significant (p < .05) potential of degree (a) or betweenness centrality (b) to predict the effect of verum aiTBS [Color
figure can be viewed at wileyonlinelibrary.com]
TABLE 7 Statistical information about the nodes showing significant (p < .05) biomarker potential
Node number Node name Correlation coefficient Slope p value
Degree
85 R insula 0.61 0.03 .007
178 L frontal superior 0.49 0.03 .038
191 L inferior parietal −0.52 −0.03 .027
259 L inferior parietal −0.53 −0.03 .025
271 R amygdala 0.53 0.03 .023
Betweenness centrality
9 R middle temporal −0.60 −0.01 .008
14 L medial somotomotor −0.52 −0.01 .03
16 R supp motor area −0.52 −0.01 .03
47 L supp motor area −0.68 −0.01 .002
60 R cingulo-opercular −0.69 −0.01 .001
62 R superior temporal (auditory) −0.62 −0.01 .006
77 L precuneus 0.56 0.01 .017
79 L midd temporal −0.51 −0.01 .03
86 L angular −0.55 −0.01 .018
93 R precuneus −0.59 −0.01 .010
116 R middle temporal −0.57 −0.01 .013
146 L Calcarine 0.60 0.01 .009
154 L occipital inferior 0.56 0.01 .015
164 L middle occipital 0.47 0.01 .049
165 R fusiform 0.52 0.02 .029
170 R Calcarine 0.54 0.01 .021
186 R frontoparietal −0.56 −0.01 .017
199 R inferior parietal −0.56 −0.01 .017
204 R supramarginal −0.48 −0.01 .017
242 L frontal inferior −0.49 −0.01 .039
256 R occipital superior −0.52 −0.01 .028
268 L caudate nucleus 0.50 0.01 .036
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As TMS has been linked to changes in psychomotor performance
before in the healthy as well as depressed state, this is of interest to
explain to some extent the working mechanisms of this kind of stimu-
lation. For instance, Baeken et al. (2010a) found improved psychomo-
tor performance after high-frequency rTMS treatment in medication
resistant depressed patients. Also Hoeppner et al. (2010) showed a
trend toward reduction of psychomotor agitation in MDD after high
frequency rTMS. Our current findings indicate that left DLPFC aiTBS
indeed may affect cortical areas involved in (psycho)motor actions.
In addition, more exploratory analyses revealed that the aiTBS
treatment protocol shows effects on several (sub)cortical areas that
can be linked to the pathophysiology of depression. For example, the
effects of sham and verum aiTBS on degree differ in the left cingulo-
opercular nodes, which are part of the cingulo-opercular network
comprising the bilateral dorsal anterior cingulate cortices (dACC), the
anterior insula, anterior prefrontal cortex, and the anterior thalamus
(Sylvester et al., 2012). This network integrates visceral, autonomic,
and sensory data to assess the homeostatic relevance or “salience” of
internal and external stimuli, and the maintenance of tonic alertness
or sustained attention (Sadaghiani & D'Esposito, 2015). The network
also clears noisy information, suppresses distraction, and keeps cogni-
tive faculties available for current processing demands (Sadaghiani &
D'Esposito, 2015). Abnormalities in this network have been reported
for obsessive compulsive disorder (OCD) (de Vries et al., 2017), psy-
chosis (Sheffield et al., 2017), and mood and anxiety disorders
(de Witte & Mueller, 2016). Of interest, Wu et al. (Wu et al., 2016)
showed that depression symptom severity was significantly correlated
with the connectivity values of this network. Indeed, increased activ-
ity in the dACC or insula during response conflict has been reported
during negative mood states (Disner, Beevers, Haigh, & Beck, 2011).
Furthermore, several nodes that showed significantly different
effects of verum and sham aiTBS, such as for example the parahippo-
campal nodes, nodes within the prefrontal cortex, and the posterior
cingulum node, belong to the default mode network (DMN). The
DMN is found to be activated during resting-state functional imaging
and de-activated when performing cognitive tasks (Fox et al., 2005;
Smith et al., 2009). When the brain is not engaged in externally driven
cognitive processing, self-referential processes are believed to pre-
dominate (Gusnard, Akbudak, Shulman, & Raichle, 2001). When clini-
cally depressed, more activity in the DMN is observed (Disner et al.,
2011). Changes in DMN activation have earlier been linked to anti-
depressant responses.
4.2 | Spatial distribution of aiTBS effects
Previous studies have already shown distributed “network-effects” of
TMS (Fox et al., 2013; Fox et al., 2014). In this study, using nodes
showing significantly different effects between verum and sham stim-
ulation, the correlation between effect sizes and functional connectiv-
ity strengths did not reach significance. This indicates that the
propagation of aiTBS-effect from the stimulated area is not directly
linked to the strength of the functional connections. Considering the
network-hypothesis, we hypothesize that the indirect effects of TMS
occur at different levels. After the activation of brain areas connected
to the stimulation site are activated, in the following steps, the brain
areas connected to those areas are activated and so on. This could, at
least partly, explain the occurrence of increases and decreases in
graph measures in distinct areas of the brain.
4.3 | Graph measures as biomarker
Clinical improvement was associated with higher baseline clustering
coefficient or global efficiency on the whole-brain level. This indicates
that all nodes within the whole brain are better integrated. The effect
of verum stimulation therefore seems to propagate more easily
through the whole-brain via functional connections, also to deeper
structures involved in the deregulated neurocircuitry of depression.
On the nodal level, we found that graph measures in multiple
nodes showed potential to predict the clinical effect. For example, a
positive correlation between the baseline betweenness centrality and
clinical effect was found in the left caudate nucleus. So lower
betweenness centrality might be advantageous for clinical outcome.
Given that the caudate has neural innervation from amongst others
the prefrontal cortex, our left caudate nucleus findings could be linked
to the application of left-sided stimulation (Kang et al., 2016). Indeed,
stronger connectivity between the dorsal prefrontal cortex and the
(dorsal) caudate has been associated with depression severity
(Furman, Paul Hamilton, & Gotlib, 2011; Kerestes et al., 2015). Fur-
thermore, observations of increased connectivity with the DLPFC and
the more ventral parts of the ACC in MDD was associated with
heightened cognitive regulation of affect, usually problematic when
clinically depressed; whereas reduced connectivity with the caudate
results in worsening symptoms such as anhedonia, reduced motiva-
tion, and psychomotor dysfunction (Davey, Harrison, Yücel, & Allen,
2012). Of note, although the sgACC was not implicated in our find-
ings, the structural and functional connections between the striatum
(caudate) and the (sg)ACC are well known (Gabbay et al., 2013). In
treatment-resistant depression, the sgACC has been proposed as bio-
marker for response for a variety of interventions, including rTMS
treatment (Fox et al., 2012; Fox et al., 2013; Weigand et al., 2017).
However, for the latter application, the functional connectivity find-
ings are not that straightforward (Baeken et al. 2017a; Baeken et al.,
2014) and the aiTBS treatment delivered to the left DLPFC may have
different neurobiological effects on the reward system (including the
caudate), based on the level of anhedonia in the depressive state
(Duprat, Wu, De Raedt, & Baeken, 2017). Indeed, it remains to be
determined whether the left DLPFC is the best target to stimulate.
Other prefrontal areas, such as the dorsomedial prefrontal cortex have
been successfully stimulated in depressed patients (Downar et al.,
2014), and alternatively when facing nonresponse, the right orbito-
frontal cortex (OFC) was found to be an excellent alternative (Feffer
et al., 2018). The right OFC is considered as a ‘non-reward’ nexus
(Cheng, Rolls, Qiu, Liu, & Tang, 2016) showing reduced functional con-
nectivity in MDD patients. Together with our own findings on clinical
improvement combined with baseline striatal (caudate) betweenness
centrality, these observations suggest that left DLPFC aiTBS could be
successful for a selected cohort of patients.
Furthermore, the degree in the right amygdala was significantly
correlated with the clinical effects of verum aiTBS, suggesting that
less connections to the right amygdala could be predictive for better
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clinical responses. Given that the amygdalae are involved in (in)effec-
tive emotion regulation in stress-related disorders (Gold & Chrousos,
2002; Perlman et al., 2012) and in particular the right amygdala is
implicated when processing negative information stressful events
(Baeken et al., 2010b; Mothersill & Donohoe, 2016), it is of interest to
note that increased baseline and sustained amygdala activity to anti-
depressant treatment is associated with clinical nonresponse in major
depression (Fonseka, Macqueen, & Kennedy, 2018).
4.4 | General limitations
This study has some general limitations that need to be considered.
Notwithstanding that rs-fMRI is a unique and powerful tool to investi-
gate human brain organization, it is based on an inherently ambiguous
measure reflecting dynamic couplings that are not yet fully under-
stood. Interscan rs-fMRI data have shown great variability. For exam-
ple, Ning et al. (2017) aimed to derive the optimal TMS stimulation
position based on functional connectivity between the DLPFC and
the sgACC and showed different results using resting-state data from
same subjects at different time-points. Longer rs-fMRI scans were
suggested to reduce this variability. Moreover, various patient-specific
factors may also influence the outcome of a stimulation protocol
(Silvanto & Pascual-Leone, 2008). As referred to earlier, Drysdale
et al. (2016) has shown that the sub-type of depression could be
related to the response to stimulation. Furthermore, the sustainability
of the effects of aiTBS, or any type of stimulation treatment, are not
yet exactly known. Pascual-Leone et al. (1996) showed clinical
responses in MDD patients for up to 6 weeks. Changes in functional
connectivity are mostly reported on shorter time-scales. EEG func-
tional connectivity showed changes up to 70 min after rTMS (Thut &
Pascual-Leone, 2010). Also, changes might be specific over time, for
example, Tik et al. (2017) only showed increased functional connectiv-
ity after 15 min, but not after 30 min, of rTMS. In this study, the
effect of aiTBS was determined 3 days after the last stimulation ses-
sion. Even though, aiTBS is a much more intense stimulation protocol
compared to single day rTMS, changes in functional connectivity
might have already faded out after 3 days.
5 | CONCLUSION
This study showed that there are no differences between the effects
of verum and sham stimulation on whole-brain graph measures and
that changes in graph measures are not correlated with clinical
response. However, baseline values of clustering coefficient and
global efficiency were found to have predictive value of the clinical
response to verum aiTBS. On the nodal level, differences between
sham and verum aiTBS were found throughout the whole brain, indi-
cating that the effects of aiTBS distribute beyond the actual stimula-
tion target. Knowledge about both functional connectivity changes
and the potential use of graph measures as biomarkers could be
important additions to novel neurostimulation protocols, as not only a
better understanding on the underlying working mechanisms of aiTBS
on the depressed brain may provide more insights, it may also guide
future stimulation protocols to ameliorate treatment outcome.
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APPENDIX A: ADDITIONAL INFORMATION ON PREPROCESSING
MOTION PARAMETERS
Overview of the number of volumes per patient after removing the ones with framewise displacement >.3. Datasets with <200 volumes were dis-
carded from further analysis. Note from Figure A1 that 5 datasets in T1 show excessive motion versus 6 in T2. With four overlapping datasets,
this led to removal of 7 datasets for further analyses.
NODE SELECTION
The first 264 nodes are resulting from the Power parcellation, as described in Power et al. (2011)). Thirteen additional nodes were appended, in
accordance to Drysdale et al. (2016). An overview can be found in Table A1.
FIGURE A1 Number of volumes included in the analysis (FWD < 0.3) for every subject, per time-point [Color figure can be viewed at
wileyonlinelibrary.com]
TABLE A1 Nodes that were added to the parcellation scheme proposed by Power et al. (2011))
Node number X (MNI) Y (MNI) Z (MNI) Node name
265 −9 10 −10 Nucleus accumbens (L)
266 10 10 −9 Nucleus accumbens (R)
267 1 25 −11 sgACC
268 −14 12 12 Caudate nucleus (L)
269 14 12 12 Caudate nucleus (R)
270 −20 −4 −15 Amygdala (L)
271 22 −2 −15 Amydala (R)
272 −28 −22 −12 Ventral hippocampus (L)
273 28 −22 −12 Ventral hippocampus (R)
274 −6 −38 −30 Locus coeruleus (L)
275 6 −36 −28 Locus coeruleus (R)
276 −4 −15 −9 VTA
277 0 −32 −24 Raphe nucleus
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TSNR
Figure A2 displays an overview of the mean tSNR (averaged over patients) per node. The nodes that were discarded for further analysis are listed
in Table A2.
APPENDIX B: GRAPH PARAMETER OVERVIEW
Figures B1 and B2 show the distributions of whole-brain graph measures for the subgroup of patients receiving sham and verum aiTBS,
respectively.
FIGURE A2 Overview of mean tSNR and standard deviation averaged over all subjects, per node. Nineteen nodes showed tSNR < 40 in more
than 10% of the datasets and were excluded for further analysis (Table A2) [Color figure can be viewed at wileyonlinelibrary.com]
TABLE A2 Nodes that were removed from further analysis because the tSNR requirements were not reached
Node number MNIx MNIy MNIz Node name
1 −25 −98 −12 Left occipital interior
2 27 −97 −13 Right occipital inferior
4 −56 −45 −24 Left temporal inferior
5 8 41 −24 Right rectus
8 −37 −29 −26 Left fusiform
10 52 −34 −27 Right temporal inferior
27 −38 −27 69 Precentral left
37 −38 −15 69 Left somatosensory
75 6 67 −4 Right medial orbitofrontal
78 −18 63 −9 Left superior orbitofrontal
83 −68 −23 −16 Left middle temporal
114 −20 64 19 Left superior frontal
140 8 −91 −7 Right lingual
141 17 −91 −14 Right lingual
142 −12 −95 −13 Left lingual
182 −21 41 −20 Left middle orbitofrontal
247 33 −12 −34 Right temporal inferior
250 −50 −7 −39 Left temporal inferior
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FIGURE B1 Overview of whole-brain graph measures for subgroup of patients (n = 14) who received sham aiTBS during the first week of the
stimulation protocol [Color figure can be viewed at wileyonlinelibrary.com]
FIGURE B2 Overview of whole-brain graph measures for subgroup of patients (n = 18) who received verum aiTBS during the first week of the
stimulation protocol [Color figure can be viewed at wileyonlinelibrary.com]
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APPENDIX C: FULL OVERVIEW OF CORRELATIONS BETWEEN CHANGES IN GRAPH MEASURES AND
CHANGES IN CLINICAL WELL-BEING IN NODES SHOWING SIGNIFICANT EFFECTS OF STIMULATION
A full overview of correlations between changes in graph measures and changes in clinical well-being in nodes showing significant effects of stim-
ulation can be found in Table C1.
TABLE C1 Full overview of correlations between changes in graph measures and changes in clinical well-being in nodes showing significant
effects of stimulation
All subjects Sham stimulated subjects Verum stimulated subjects
Node number Correlation coefficient p value Correlation coefficient p value Correlation coefficient p value
Degree
17 −0.0452 0.8061 −0.0105 0.9717 −0.2375 0.3427
29 0.2749 0.1278 −0.118 0.6878 0.3886 0.111
46 −0.1538 0.4007 0.0406 0.8905 −0.1743 0.4891
51 −0.0663 0.7185 0.1236 0.6737 −0.0243 0.9237
53 0.2027 0.2659 0.2112 0.4686 0.3676 0.1334
57 0.098 0.5935 −0.1127 0.7013 0.0829 0.7437
59 0.1546 0.3982 0.308 0.2841 0.2623 0.2931
65 −0.011 0.9526 −0.2247 0.4399 0.3092 0.2119
69 −0.0686 0.7091 0.0415 0.8879 −0.3547 0.1487
112 0.0411 0.8235 0.0131 0.9645 0.2892 0.2445
113 0.1355 0.4595 0.224 0.4413 0.2288 0.3611
119 −0.2307 0.2039 0.152 0.604 −0.4557 0.0573
124 −0.0723 0.6943 −0.5791 0.03 −0.031 0.9028
167 −0.1504 0.4114 −0.3954 0.1617 0.0712 0.7788
218 −0.0583 0.7511 −0.034 0.908 0.0484 0.8489
233 0.3357 0.0603 0.3958 0.1613 0.2184 0.3839
243 −0.1695 0.3537 −0.3481 0.2227 −0.2205 0.3792
260 −0.084 0.6477 −0.2677 0.3547 −0.0759 0.7646
Betweenness centrality
7 −0.255 0.1589 −0.0173 0.9532 −0.2897 0.2436
16 0.1441 0.4314 0.2126 0.4656 −0.1616 0.5217
17 −0.0247 0.8934 −0.024 0.9351 −0.2211 0.378
29 −0.1332 0.4674 −0.11 0.7081 −0.032 0.8997
45 0.596 0.0003 0.6874 0.0066 0.5075 0.0316
63 0.4115 0.0193 0.2543 0.3802 0.4287 0.0759
64 0.0122 0.9471 0.5075 0.064 −0.2301 0.3583
97 0.247 0.173 0.1566 0.5929 0.189 0.4525
101 0.3499 0.0497 0.3261 0.2551 0.2696 0.2794
119 −0.2289 0.2077 −0.4309 0.124 0.0293 0.908
124 0.1761 0.3349 0.2405 0.4076 0.3206 0.1946
133 −0.0752 0.6826 −0.1231 0.6751 −0.0.2093 0.4046
154 0.1378 0.452 −0.0042 0.9887 0.0901 0.7222
161 0.1588 0.3854 −0.25 0.3887 0.2791 0.2621
179 −0.0191 0.9175 −0.0158 0.9572 −0.1837 0.4655
196 0.1062 0.563 −0.0731 0.8039 0.1791 0.4771
198 −0.2706 0.1341 0.0539 0.8547 −0.3695 0.1313
213 −0.3315 0.0638 0.0391 0.8945 −0.6532 0.0033
227 −0.1596 0.3829 −0.1797 0.5388 0.0162 0.949
228 −0.279 0.122 −0.1476 0.6145 −0.2986 0.2287
235 −0.0431 0.8148 −0.0629 0.8307 0.1389 0.5825
268 −0.0992 0.5893 0.0465 0.8747 −0.0714 0.7784
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